Bayer Aktiengesellschaft (BAYN.DE)
Makes medicines, over-the-counter health products, and crop protection chemicals for global markets.
47.03-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+67.2%
The outlook
Bayer is trading at 47.03, positioned well above its 50- and 200-day moving averages with solid upward momentum. Analysts lean Buy with an average target around 17% above the current price. The stock sits in the upper portion of its 52-week range, reflecting strength over the past year.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 18 analysts
Price trendAbove its 50- & 200-day averages
52-week range76% of the way from its 52-week low to high
Price targetAvg target +17% vs current price
Analyst price target
~12-month · 18 analysts54.92average target+16.8% vs now
Now 47.03
Low 46.00High 65.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$46.20B
52-wk high
53.92
52-wk low
24.81
50-day avg
42.41
200-day avg
38.69
Trailing P/E
—